Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
02566.HK
JIUYUAN GENE (02566.HK): JY54-2 IND Accepted for Diabetes, Weight
Tags:
JIUYUAN GENE
02566.HK
Clinical Trial
2026-11-06
JIUYUAN GENE(02566.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 91.27 million, YoY increase of 1.21%
Tags:
JIUYUAN GENE
02566.HK
profit
2026-08-20
Jiuyuan Gene (02566.HK): JY47 Injection Receives NMPA Implicit Clinical Trial Approval for MASH with Liver Fibrosis
Tags:
JIUYUAN GENE
02566.HK
IND application
2026-03-17
JIUYUAN GENE (02566.HK): IND Application for JY54 Injection Accepted by CDE, Focusing on Weight Management
Tags:
JIUYUAN GENE
02566.HK
2026-02-09
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App